Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Int J Infect Dis ; 90: 151-160, 2020 Jan.
Article in English | MEDLINE | ID: mdl-31672657

ABSTRACT

BACKGROUND: Despite the considerable disease burden caused by the disease, rotavirus vaccine has not been introduced into routine national immunization schedule, and norovirus vaccines are being developed without a comprehensive understanding of gastroenteritis epidemiology. To bridge this knowledge gap, we investigated the disease burden of viral gastroenteritis in rural China. METHODS: Between October 2011 and December 2013, population-based surveillance was conducted in Zhengding and Sanjiang counties in China. Stool samples were collected from children <5 years of age with diarrhea. All specimens were tested for rotaviruses, noroviruses, sapoviruses, enteric adenoviruses, and astroviruses. RESULTS: The most common pathogen causing diarrhea was rotavirus (54.7 vs 45.6 cases/1,000 children/year in Zhengding and Sanjiang, respectively), followed by norovirus (28.4 vs 19.3 cases/1,000 children/year in Zhengding and Sanjiang, respectively). The highest incidence of these viruses was observed in children 6-18 months of age. Among the 5 viral pathogens, rotaviruses caused the most severe illness, followed by noroviruses. CONCLUSION: Rotavirus and norovirus are the 2 most important viral pathogens causing childhood diarrhea in both northern and southern China; they should be the major targets for viral gastroenteritis prevention strategies among children in China.


Subject(s)
Gastroenteritis/virology , Virus Diseases/virology , Viruses/isolation & purification , Child, Preschool , China/epidemiology , Diarrhea/epidemiology , Diarrhea/virology , Feces/virology , Female , Gastroenteritis/epidemiology , Humans , Incidence , Infant , Male , Population Surveillance , Rural Population/statistics & numerical data , Virus Diseases/epidemiology , Viruses/classification , Viruses/genetics
2.
Pharmacotherapy ; 39(10): 994-1004, 2019 10.
Article in English | MEDLINE | ID: mdl-31411762

ABSTRACT

OBJECTIVES: Few studies have investigated the prophylactic efficacy of dexmedetomidine (DEX) in postpartum depressive symptoms (PDS). A randomized double-blind placebo-controlled trial was conducted to investigate whether the administration of DEX, immediately after delivery and for patient-controlled intravenous analgesia (PCIA), can attenuate PDS. METHODS: A total of 600 parturients scheduled for elective cesarean delivery under spinal anesthesia were randomly allocated into the control group (infusion with 0.9% normal saline after delivery and PCIA with sufentanil) and the DEX group (DEX infusion 0.5 µg/kg after delivery and PCIA with DEX plus sufentanil). The prevalence of postpartum depressive disorders was indicated by the Edinburgh Postnatal Depression Scale (EPDS). Postoperative analgesia, sedation, and sleep quality of parturients were also assessed. RESULTS: Postpartum blues and PDS prevalence in the DEX, versus control, group were significantly lower (5.0% vs 14.1%, p<0.001; 5.7% vs 16.3%, p<0.001, respectively), especially in parturients with antenatal depression or moderate stress during pregnancy. Compared with the control group, the EPDS score at postpartum days 7 and 42 in the DEX group was significantly lower (4.23 ± 4.37 vs 1.93 ± 3.36, p<0.001; 4.68 ± 4.78 vs 1.99 ± 3.18, p<0.001, respectively), as was the incidence of postpartum self-harm ideation at postpartum days 7 and 42 in the DEX group versus the control group (1.1% vs 4.0%, p=0.03; 0.4% vs 2.9%, p=0.04, respectively). The pain score and the sleep quality in the DEX group were better than that in the control group (p<0.001). CONCLUSION: The application of DEX in the early postpartum period can significantly attenuate the incidence of postpartum depressive disorders.


Subject(s)
Analgesia, Obstetrical , Cesarean Section , Depression, Postpartum/prevention & control , Dexmedetomidine/administration & dosage , Adult , Analgesia, Obstetrical/adverse effects , Analgesia, Obstetrical/methods , Analgesics, Non-Narcotic/administration & dosage , Cesarean Section/adverse effects , Cesarean Section/methods , Depression, Postpartum/diagnosis , Depression, Postpartum/epidemiology , Double-Blind Method , Female , Humans , Incidence , Outcome Assessment, Health Care , Pregnancy , Psychiatric Status Rating Scales , Sleep Hygiene/drug effects
3.
J Infect ; 75(3): 216-224, 2017 09.
Article in English | MEDLINE | ID: mdl-28633888

ABSTRACT

BACKGROUND: To understand the epidemiology and disease burden of norovirus (NoVs) gastroenteritis in China, a systematic review was conducted. METHODS: Studies on acute gastroenteritis (AGE) caused by NoVs from mainland China, published before 2017 were searched. All retrieved articles were screened and reviewed by a standardized algorithm. NoVs detection rates as well as strain variations by ages, seasonal variations and geographic locations were analyzed using random-effects model. RESULTS: A total of 225 articles were included in the final analysis. Similar detection rates at 21.0% and 19.8% were obtained from the North and the South, respectively. NoVs infection occurred year round, with a peak between October and January in the North and between August and November in the South. High detection rates (∼29%) of NoVs were found in adults and the elderly and in children aged 6-35 months (∼22%). The predominant strains were GII.4 (70.4%), followed by GII.3 (13.5%). CONCLUSION: NoVs cause significant disease burden in China which warrants development of vaccines against NoVs, particularly for children and the elderly who are vulnerable to gastroenteritis diseases. To achieve a broad protection, continual monitoring NoV epidemics and strain variations for selection of proper vaccine strains is critical.


Subject(s)
Caliciviridae Infections/epidemiology , Caliciviridae Infections/virology , Gastroenteritis/epidemiology , Gastroenteritis/virology , Norovirus/genetics , Acute Disease , Adult , Aged , Child , Child, Preschool , China/epidemiology , Cost of Illness , Epidemics , Feces/virology , Female , Genotype , Humans , Infant , Norovirus/isolation & purification , Phylogeny , Prevalence , RNA, Viral/genetics , Seasons
4.
Infect Genet Evol ; 53: 199-205, 2017 09.
Article in English | MEDLINE | ID: mdl-28603022

ABSTRACT

To understand the distribution of genotyping, as well as evolution of norovirus circulating among children<5yrs., a population-based diarrhea surveillance targeted children<5yrs. was conducted in rural Zhengding County, Hebei Province, China between October 2011 and March 2012. RT-PCR was used to amplify the capsid-encoding region of GI and GII norovirus to identify norovirus infection. All PCR products were sequenced and analyzed for genotyping and constructing phylogenetic tree. Dynamic distribution network was constructed by TempNet to illustrate the genetic relationships at two different time points. Bayesian evolutionary inference techniques were applied by BEAST software to study the norovirus evolution rate. During the 6-month surveillance period, 1091 episodes of diarrhea were reported from 5633 children under 5years of age lived in catchment area. 115 of 1091 stool specimens were detected as norovirus positive (10.54%). Five genotypes based on capsid gene sequences were identified, including GII.2 (11), GII.3 (52), GII.4 (47), GII.6 (4) and GII.7 (1). An identical haplotype of GII.4 circulated between 2006 and 2011 in Hebei Province. A mean rate of 6.29×10-2 nucleotide substitutions/site/year (s/s/y) was obtained for GII.3 viruses in Hebei, while the GII.4 viruses evolved at a mean rate of 3.67×10-2s/s/y. In conclusions, GII.3 (45.22%) and GII. 4(40.87%) are the predominant strain in Hebei Province in the winter season of 2011 and 2012. Different from the current consensus, our study shows that GII.3 noroviruses in Hebei Province evolved at a faster rate than GII.4 viruses.


Subject(s)
Caliciviridae Infections/epidemiology , Capsid Proteins/genetics , Diarrhea/epidemiology , Norovirus/genetics , Phylogeny , RNA, Viral/genetics , Bayes Theorem , Caliciviridae Infections/diagnosis , Caliciviridae Infections/virology , Child, Preschool , China/epidemiology , Diarrhea/diagnosis , Diarrhea/virology , Evolution, Molecular , Feces/virology , Female , Genetic Variation , Haplotypes , Humans , Infant , Infant, Newborn , Male , Molecular Typing , Norovirus/classification , Norovirus/isolation & purification , Sequence Analysis, DNA
5.
Emerg Microbes Infect ; 4(10): e64, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26576341

ABSTRACT

A universal rotavirus (RV) immunization program is a potentially cost-effective measure for preventing RV infection in China. However, the efficacy of the only licensed RV vaccine (Lanzhou lamb rotavirus vaccine, LLR), which is made by a domestic manufacturer, has not been proven by a properly designed clinical trial. In October 2011 to March 2012, to measure the potential protection provided by LLR, a case-control study nested in a population-based active diarrhea surveillance study of children <5 years of age was conducted in rural Zhengding county. During the study period, 308 episodes of diarrhea were identified as being caused by RV infection, resulting in an incidence rate of 48.0/1000 people/year. The predominant RV serotype was G3 (61.5%), followed by G1 (15.2%), and G9 (6.5%). Overall, a protection of 35.0% (95% confidence interval (CI), 13.0%-52.0%) was identified, and higher protection was found among moderate RV gastroenteritis cases caused by the serotype G3 (52.0% 95% CI: 2.0%-76.1%). A concurrently conducted case-control study comparing non-RV viral diarrheal cases with non-diarrheal controls in the same population found that the RV vaccine offered no protection against non-RV diarrhea. Even under a less ideal immunization schedule, the oral LLR conferred a certain level of protection against RV gastroenteritis. However, further studies are needed to understand the full characteristics of the LLR, including its efficacy when administered following the optimal regimen, the potential risk of inducing intussusception, and the direct and indirect protective effects of LLR.


Subject(s)
Diarrhea/prevention & control , Gastroenteritis/prevention & control , Rotavirus Infections/prevention & control , Rotavirus Vaccines/standards , Administration, Oral , Animals , Case-Control Studies , Child, Preschool , China , Cohort Studies , Diarrhea/virology , Feces/virology , Gastroenteritis/virology , Genotyping Techniques , Humans , Infant , Odds Ratio , Population Surveillance , Rotavirus/classification , Rotavirus/genetics , Rotavirus/isolation & purification , Rotavirus Infections/virology , Rotavirus Vaccines/administration & dosage , Severity of Illness Index , Sheep , Surveys and Questionnaires , Vaccines, Attenuated/administration & dosage , Vaccines, Attenuated/standards
6.
PLoS One ; 9(1): e84699, 2014.
Article in English | MEDLINE | ID: mdl-24416267

ABSTRACT

BACKGROUND: We conducted a systematic review of the diversity and fluctuation of group A rotavirus strains circulating in China. METHODS AND FINDINGS: Studies of rotavirus-based diarrhea among children less than 5 years, published in English or Chinese between 1994 and 2012, were searched in PubMed, SinoMed, and CNKI and reviewed by applying standardized algorithms. The temporal and spatial trends of genotyping and serotyping were analyzed using a random-effects model. Ninety-three studies met the inclusion/exclusion criteria and were included in the meta-analysis. Overall, 22,112 and 10,660 rotavirus samples had been examined for G and P types, respectively. The most common G types were G1 (39·5%), G3 (35·6%), G2 (1·3%), and G9 (0·1%). Among P types, P[8] (54·6%) was the predominant type, followed by P[4] (11·1%) and P6 (0·1%). The most common G-P combinations were G3P[8] (32·1%) and G1P[8] (24·5%), followed by G2P[6] (13·2%) and G2P[4] (10·1%). Before 2000, serotype G1 was the predominant strain and accounted for 74·3% of all rotavirus infections; however, since 2000, G3 (45·2%) has been the predominant strain. Rotavirus P types showed little variation over the study period. CONCLUSION: Despite the variation of serotypes observed in China, the G1, G2, G3, and G4 serotypes accounted for most rotavirus strains in recent decades. These results suggest that Chinese children will be adequately protected with currently available or forthcoming rotavirus vaccines.


Subject(s)
Asian People/statistics & numerical data , Biodiversity , Diarrhea/virology , Rotavirus/classification , Rotavirus/physiology , Child , Geography , Humans , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL